Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Von Hippel-Lindau disease].

T Shuin1, S Ashida, M Yao

  • 1Department of Urology, Kochi Medical School.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 2, 2000
PubMed
Summary

Von Hippel-Lindau (VHL) disease, a genetic disorder causing tumors, is linked to mutations in the VHL gene. Early DNA testing for VHL disease can improve patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Skin-limited arteritis of small muscular arteries with giant cell-rich granulomatous inflammation in a patient with polymyalgia rheumatica.

Scandinavian journal of rheumatology·2018
Same author

Axonal TDP-43 aggregates in sporadic amyotrophic lateral sclerosis.

Neuropathology and applied neurobiology·2016
Same author

Therapeutic implication of genetic variants of IL13 and STAT4 in airway remodelling with bronchial asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2016
Same author

Increased Facet Fluid Predicts Dynamic Changes in the Dural Sac Size on Axial-Loaded MRI in Patients with Lumbar Spinal Canal Stenosis.

AJNR. American journal of neuroradiology·2015
Same author

Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET.

Oncogenesis·2013
Same author

Application of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET imaging to predict highly malignant tumor grades and hypoxia-inducible factor-1α expression in patients with glioma.

AJNR. American journal of neuroradiology·2012

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome.
  • It is characterized by the development of tumors in various organs, including the central nervous system (CNS), adrenal glands (pheochromocytoma), and kidneys (renal cell carcinoma).
  • The VHL gene, a tumor suppressor, is implicated in the disease's pathogenesis.

Purpose of the Study:

  • To investigate the role of the VHL gene in VHL disease.
  • To understand the mutation patterns within the VHL gene.
  • To highlight the importance of genetic testing for early diagnosis and improved prognosis.

Main Methods:

  • Analysis of germline mutations in the VHL gene.
  • Classification of VHL disease into types 1 (without pheochromocytoma) and 2 (with pheochromocytoma).
  • Investigation of the VHL protein's function in protein degradation pathways.

Main Results:

  • Germline mutations in the VHL gene are the cause of VHL disease.
  • These mutations are often missense and cluster in specific regions of the VHL gene.
  • The VHL protein plays a crucial role in the ubiquitination and degradation of hypoxia-inducible factors (HIFs).

Conclusions:

  • VHL disease is caused by mutations in the VHL tumor suppressor gene.
  • Understanding mutation locations and VHL protein function is key.
  • Presymptomatic diagnosis through DNA analysis is vital for managing VHL disease and improving patient prognosis.

Related Experiment Videos